Nice reference to Todos and Tollovid in this, uh-o
Post# of 1418
(Total Views: 219)
Posted On: 05/25/2022 2:24:59 PM
Nice reference to Todos and Tollovid in this, uh-oh Pfizer Paxlovid article today...
Concerns Mount Over COVID-19 'Rebounds' After Treatment With Pfizer's Paxlovid - Published: May 25, 2022
"Prior to the CDC’s announcement, the red flag had already been waved. At the beginning of May, 3CL Pharma Ltd., a Todos Medical Ltd. subsidiary, released data from a 30-day case study of a patient who had experienced COVID-19 rebound infection after taking a full course of Paxlovid. The data reported that the patient had severe symptom recurrence on the final day of the Paxlovid treatment regimen.
The hypothesis given is that, in some patients with long COVID-19, the recurrent infection occurs because the body can elude the vaccine or resist building immune memory following infection. The study has an additional interest in whether cases of post-Paxlovid rebound may be successfully treated with 3CL’s immune dietary supplement Tollovid."
https://www.biospace.com/article/concerns-mou...ment/?s=91
Concerns Mount Over COVID-19 'Rebounds' After Treatment With Pfizer's Paxlovid - Published: May 25, 2022
"Prior to the CDC’s announcement, the red flag had already been waved. At the beginning of May, 3CL Pharma Ltd., a Todos Medical Ltd. subsidiary, released data from a 30-day case study of a patient who had experienced COVID-19 rebound infection after taking a full course of Paxlovid. The data reported that the patient had severe symptom recurrence on the final day of the Paxlovid treatment regimen.
The hypothesis given is that, in some patients with long COVID-19, the recurrent infection occurs because the body can elude the vaccine or resist building immune memory following infection. The study has an additional interest in whether cases of post-Paxlovid rebound may be successfully treated with 3CL’s immune dietary supplement Tollovid."
https://www.biospace.com/article/concerns-mou...ment/?s=91
(1)
(0)